Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
Toshiko Kobori, Yukiko Onishi, Yoko Yoshida, et al.
Journal of Diabetes Investigation (2023) Vol. 14, Iss. 6, pp. 767-773
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Delayed Gastric Emptying with Perioperative Use of Glucagon-like Peptide-1 Receptor Agonists
Lisa M. Raven, Alina Stoita, Robert B Feller, et al.
The American Journal of Medicine (2023) Vol. 136, Iss. 12, pp. e233-e234
Open Access | Times Cited: 21
GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment
Justin W. L. Wan, Caesar Ferrari, Micheal Tadros
Gastroenterology Insights (2024) Vol. 15, Iss. 1, pp. 191-212
Open Access | Times Cited: 8
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis
Tatiana S. do Nascimento, Rodrigo O. L. Pereira, Eduardo Habib Bechelane Maia, et al.
Perioperative Medicine (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly—Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying
Henry P. Parkman, Daniel Rim, Jonathan Anolik, et al.
Journal of Nuclear Medicine Technology (2024) Vol. 52, Iss. 1, pp. 3-7
Open Access | Times Cited: 7
Safe Continuation of Glucagon-like Peptide 1 Receptor Agonists at Endoscopy: A Case Series of 57 Adults Undergoing Endoscopic Sleeve Gastroplasty
Daniel B. Maselli, Daniel J. Lee, Danse Bi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 7, pp. 2369-2374
Closed Access | Times Cited: 6
Risk of Aspiration Pneumonitis After Elective Esophagogastroduodenoscopy in Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ruaa Al Sakka Amini, Abdellatif Ismail, Maysarah Mahdi Alaqrabawi, et al.
Cureus (2024)
Open Access | Times Cited: 6
Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center
Ernesto Robalino Gonzaga, Aimen Farooq, Abdul Mohammed, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5403-5403
Open Access | Times Cited: 6
Perioperative Management of Patients Taking Glucagon-like Peptide-1 Receptor Agonists: Applying Evidence to Clinical Practice
Adriana D. Oprea, Guillermo E. Umpierrez, BobbieJean Sweitzer, et al.
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1141-1161
Closed Access | Times Cited: 6
Perioperative Considerations for Patients on Semaglutide
Sher‐Lu Pai, Michael A. Smith, William B. Beam, et al.
Current anesthesiology reports (2024) Vol. 14, Iss. 2, pp. 152-160
Closed Access | Times Cited: 5
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment
Guillermo E. Umpierrez, Francisco J. Pasquel, Elizabeth W. Duggan, et al.
Journal of Diabetes Science and Technology (2024)
Open Access | Times Cited: 5
Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study
Haider Ghazanfar, Nismat Javed, A Qasim, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 26, pp. 3221-3228
Open Access | Times Cited: 5
Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon
Nathanael D. Heckmann, Ryan Palmer, Cory K. Mayfield, et al.
Arthroplasty Today (2024) Vol. 27, pp. 101327-101327
Open Access | Times Cited: 4
GLP1-RA use prior to endoscopy is associated with low retained gastric contents: a multicenter cross-sectional analysis.
Jennifer Phan, Patrick Chang, Danny Issa, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 4
Semaglutide Is an Independent Predictor of Retained Solid Gastric Contents, but Same-Day Colonoscopy Mitigates Effect
Haarika Korlipara, Jason Chua, Adam Buckholz, et al.
Techniques and Innovations in Gastrointestinal Endoscopy (2024) Vol. 26, Iss. 4, pp. 316-322
Closed Access | Times Cited: 4
The impact of glucagon-like peptide-1 receptor agonist on the gastric residue in upper endoscopy
Naim Abu‐Freha, Zohar Levi, Anat Nevo-Shor, et al.
Diabetes Research and Clinical Practice (2024), pp. 111900-111900
Closed Access | Times Cited: 4
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?
Marvin G. Chang, Juan G. Ripoll, Ernesto Lopez, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6336-6336
Open Access | Times Cited: 4
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms
Ronald Goldenberg, Jeremy Gilbert, Robyn L. Houlden, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Reem Z. Sharaiha, Alpana P. Shukla, Sudipta Sen, et al.
Gastrointestinal Endoscopy (2025) Vol. 101, Iss. 2, pp. 285-294
Open Access
Association of Semaglutide with Retained Gastric Contents on Endoscopy: A Retrospective Analysis
Garrick Gu, Connor Pauplis, Taylor Seacor, et al.
Endoscopy International Open (2025) Vol. 13, Iss. CP
Open Access
Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists
Yuan-Hsin Chen, Thomas M. Zink, Ya‐Wen Chen, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250081-e250081
Open Access
Evidence Report on the Safety of Gastrointestinal Endoscopy in Patients on Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis
Zahid Ijaz Tarar, Umer Farooq, Ahtshamullah Chaudhry, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 770-770
Open Access
Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis
Ying Tan, Xian Zhang, Xiu‐He Lv, et al.
Digestive and Liver Disease (2025)
Closed Access
A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia
Luigi Vetrugno, Cristian Deana, Andrea Da Porto, et al.
Journal of Anesthesia Analgesia and Critical Care (2025) Vol. 5, Iss. 1
Open Access
Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy – a retrospective cohort study
Chino Aneke-Nash, Kay S. Hung, Elizabeth Wall‐Wieler, et al.
BMJ Open Gastroenterology (2025) Vol. 12, Iss. 1, pp. e001704-e001704
Open Access
Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysis
Jasmin Elkin, Siddharth Rele, Priya Sumithran, et al.
Anaesthesia (2025)
Open Access

Scroll to top